This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2004 Mar;150(3):613-4.

doi: 10.1046/j.1365-2133.2004.05816.x.

Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial

M Weiner, A Stein, S Cash, J de Leoz, J-D Fine

PMID: 15030362
DOI: 10.1046/j.1365-2133.2004.05816.x

Clinical Trial

Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial

M Weiner et al. Br J Dermatol. 2004 Mar.

. 2004 Mar;150(3):613-4.

doi: 10.1046/j.1365-2133.2004.05816.x.

Authors

M Weiner, A Stein, S Cash, J de Leoz, J-D Fine

PMID: 15030362
DOI: 10.1046/j.1365-2133.2004.05816.x

No abstract available

PubMed Disclaimer

Similar articles

Evaluation of the efficacy of topical bufexamac in epidermolysis bullosa simplex. A double-blind placebo-controlled crossover trial.
Fine JD, Johnson L. Fine JD, et al. Arch Dermatol. 1988 Nov;124(11):1669-72. Arch Dermatol. 1988. PMID: 3178249 Clinical Trial.
Oral erythromycin therapy in epidermolysis bullosa simplex generalized severe.
Chiaverini C, Fontas E, Vabres P, Bessis D, Mazereeuw J, Charlesworth A, Meneguzzi G, Lacour JP. Chiaverini C, et al. Br J Dermatol. 2015 Aug;173(2):563-4. doi: 10.1111/bjd.13672. Epub 2015 Jun 10. Br J Dermatol. 2015. PMID: 25601422 No abstract available.
Treatment of epidermolysis bullosa simplex (EBS) with tetracycline.
Veien NK, Buus SK. Veien NK, et al. Arch Dermatol. 2000 Mar;136(3):424-5. doi: 10.1001/archderm.136.3.424-a. Arch Dermatol. 2000. PMID: 10724216 No abstract available.
Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.
Wally V, Hovnanian A, Ly J, Buckova H, Brunner V, Lettner T, Ablinger M, Felder TK, Hofbauer P, Wolkersdorfer M, Lagler FB, Hitzl W, Laimer M, Kitzmüller S, Diem A, Bauer JW. Wally V, et al. J Am Acad Dermatol. 2018 May;78(5):892-901.e7. doi: 10.1016/j.jaad.2018.01.019. Epub 2018 Feb 2. J Am Acad Dermatol. 2018. PMID: 29410318 Clinical Trial.
Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C. Zuckerman RA, et al. J Infect Dis. 2007 Nov 15;196(10):1500-8. doi: 10.1086/522523. Epub 2007 Oct 31. J Infect Dis. 2007. PMID: 18008230 Clinical Trial.

See all similar articles

Cited by

Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.
Wally V, Reisenberger M, Kitzmüller S, Laimer M. Wally V, et al. Orphanet J Rare Dis. 2020 Oct 19;15(1):292. doi: 10.1186/s13023-020-01467-9. Orphanet J Rare Dis. 2020. PMID: 33076941 Free PMC article. Review.
Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial.
Chiaverini C, Roger C, Fontas E, Bourrat E, Bourdon-Lanoy E, Labrèze C, Mazereeuw J, Vabres P, Bodemer C, Lacour JP. Chiaverini C, et al. Orphanet J Rare Dis. 2016 Mar 25;11:31. doi: 10.1186/s13023-016-0411-5. Orphanet J Rare Dis. 2016. PMID: 27015660 Free PMC article. Clinical Trial.
Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex.
Ablinger M, Felder TK, Wimmer M, Zauner R, Hofbauer P, Lettner T, Wolkersdorfer M, Lagler FB, Diem A, Bauer JW, Wally V. Ablinger M, et al. Orphanet J Rare Dis. 2018 Nov 1;13(1):193. doi: 10.1186/s13023-018-0940-1. Orphanet J Rare Dis. 2018. PMID: 30382914 Free PMC article. Clinical Trial.
Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study).
Paller AS, Browning J, Nikolic M, Bodemer C, Murrell DF, Lenon W, Krusinska E, Reha A, Lagast H, Barth JA; ESSENCE Study Group. Paller AS, et al. Orphanet J Rare Dis. 2020 Jun 23;15(1):158. doi: 10.1186/s13023-020-01419-3. Orphanet J Rare Dis. 2020. PMID: 32576219 Free PMC article. Clinical Trial.
Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.
Chamcheu JC, Wood GS, Siddiqui IA, Syed DN, Adhami VM, Teng JM, Mukhtar H. Chamcheu JC, et al. Exp Dermatol. 2012 Jul;21(7):481-9. doi: 10.1111/j.1600-0625.2012.01534.x. Exp Dermatol. 2012. PMID: 22716242 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources